Category Archives: General Audience

Hepatitis A and the Opioid Crisis

As the opioid crisis continues, other health consequences of drug use are on the rise. Since 2016, hepatitis A has caused more than 230 deaths. As of August, 2019, there were 494 cases of hepatitis A in Massachusetts (and seven deaths) since the onset of the local outbreak…

Read More

The Kim Jong Nam Assassination

Toxicology has been front and center in the media recently with the high-profile assassination of Kim Jong-nam ( the estranged half-brother of North Korean Supreme Leader Kim Jong-un, at the airport in Kuala Lumpur. Preliminary reports from the Malaysian government suggest that VX nerve agent was the murder…

Read More

What is Sassafras?

Recently, we’ve had several adults report using Sassafras (or “Sass”) to get high at concerts and in social situations. In researching sassafras, this is what we learned. Like Sassafras… the plant? Sort of. Safrole (4-allyl-1,2-methylenedioxy-benzene) is a phenylpropene oil derived from sassafras plants (typically root bark and fruits)….

Read More

Should Kratom Become a Schedule I Drug?

On August 31, 2016, the Drug Enforcement Administration (DEA) temporarily placed mitragynine and 7-hydroxymitragynine into Schedule I status, then withdrew the intent to schedule in favor of a public comment period until December 1, 2016. The status of Kratom remains undetermined. Mitragynine and 7-hydroxymitragynine are the active alkaloids…

Read More